Linatil Comp

Enalapril maleate, the active ingredient in Linatil Comp, is an ACE inhibitor presented as a combined oral tablet for oral use. It is used to treat hypertension, often in combination with hydrochlorothiazide, and is prescribed for adult patients requiring blood pressure control.

GNH USA supplies Linatil Comp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Its distribution network ensures timely delivery across Europe, Asia, Africa and the Americas.

Linatil Comp, containing enalapril and hydrochlorothiazide, is employed in the management of hypertension, a condition of chronically elevated arterial pressure.

- Essential hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk. - Hypertension with fluid retention: combines ACE inhibition and diuretic action to improve blood pressure and volume control. - Patients needing combination therapy: provides both agents in a single tablet, simplifying dosing and adherence.

Linatil Comp may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness, especially after the first dose. - Headache. - Fatigue. - Increased urinary frequency. - Electrolyte disturbances (e.g., low potassium).

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue or airway. - Severe hypotension: marked drop in blood pressure. - Acute renal failure or worsening kidney function. - Hyperkalemia: elevated blood potassium levels. - Pancreatitis. - Blood dyscrasias such as agranulocytosis.

Before prescribing Linatil Comp, clinicians should consider several safety precautions to minimize risk.

- Blood pressure monitoring: check regularly to avoid hypotension. - Renal function assessment: evaluate serum creatinine and eGFR before and during therapy. - Electrolyte surveillance: monitor potassium and sodium levels. - Pregnancy contraindication: avoid use in pregnancy due to fetal risk. - Elderly patients: start at lower dose and monitor for orthostatic symptoms. - Store at room temperature: keep in original packaging, protect from moisture and heat.

Linatil Comp can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Aliskiren: combined use with ACE inhibitors may increase risk of renal impairment. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalaemia. - NSAIDs (e.g., ibuprofen, naproxen): can reduce antihypertensive effect and impair kidney function.

Moderate Interactions (Monitor Closely): - Lithium: ACE inhibitors may increase lithium levels, risking toxicity. - Antidiabetic agents (e.g., insulin, sulfonylureas): may enhance hypoglycaemic effect. - Other antihypertensives (e.g., beta‑blockers, calcium channel blockers): may cause additive blood pressure lowering.